Eosinophilic Fasciitis Triggered by Nivolumab: A Remarkable Efficacy of the mTOR Inhibitor Sirolimus

Affiliations

• ¹ Internal Medicine Department, South Hospital, Rennes, France; Rennes 1 University, Rennes, France.
• ² Internal Medicine Department, South Hospital, Rennes, France; INSERM, Research Institute in Health, Environment, and Occupation, UMR_S 1085, Rennes 1 University, Rennes, France.
• ³ Internal Medicine Department, South Hospital, Rennes 1 University, Rennes, France, Rennes, France.
• ⁴ Department of Respiratory Medicine, Pontchaillou Hospital, Rennes, France; Chemistry, Oncogenesis, and Stress Signaling, INSERM U1242, Rennes 1 University, Centre Eugène Marquis, Rennes, France.
• ⁵ Internal Medicine Department, Lariboisière Hospital, Paris, France; INSERM UMR, Paris Diderot University, Paris, France.
• ⁶ Dermatology Department, AP-HP, Saint Louis Hospital, Paris, France; INSERM U976, Paris University, Paris, France.
• ⁷ Department of Internal Medicine, South Hospital, Rennes, France; INSERM, Research Institute in Health, Environment, and Occupation, UMR_S 1085, Rennes 1 University, Rennes, France.
• ⁸ Department of Internal Medicine, South Hospital, Rennes, France; Rennes 1 University, Rennes, France. Electronic address: nicolas.belhomme@chu-rennes.fr.